* Progyny Inc PGNY.OQ PGNY.O is expected to show a rise
in
quarterly revenue when it reports results on May 8.
* The New York City-based company is expected to report a
43.1% increase in revenue to $246.405 million from $172.22
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
February 27 2023, for the period ended March 31, was for revenue
between $245.00 million and $250.00 million.
* Refinitiv's mean analyst estimate for Progyny Inc is for
earnings of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 12.5%
in the last three months.
* Wall Street's median 12-month price target for Progyny Inc
is
$45.5, above its last closing price of $34.58.
The company's guidance on February 27 2023 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD245 million and USD44 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.02 0.01 0.03 Beat 157.1
Sep. 30 2022 0.06 0.05 0.13 Beat 175.8
Jun. 30 2022 0.02 0.05 0.09 Beat 100
Mar. 31 2022 0.00 0.01 0.05 Beat 525
Dec. 0.04 0.04 0.15 Beat 316.7
31 2021
Sep. 30 2021 0.06 0.06 0.17 Beat 175.1
Jun. 30 2021 0.08 0.08 0.19 Beat 131.7
Mar. 31 2021 0.08 0.08 0.15 Beat 93.1
This summary was machine generated May 6 at 02:02 GMT. All
figures in US dollars unless otherwise stated